Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Correction: Fadraciclib (CYC065), a novel CDK inhibitor, targets key pro-survival and oncogenic pathways in cancer.
PLOS ONE ( IF 2.9 ) Pub Date : 2021-05-06 , DOI: 10.1371/journal.pone.0251671
PLOS ONE ( IF 2.9 ) Pub Date : 2021-05-06 , DOI: 10.1371/journal.pone.0251671
[This corrects the article DOI: 10.1371/journal.pone.0234103.].
中文翻译:
更正:Fadraciclib(CYC065)是一种新型CDK抑制剂,靶向癌症中关键的促生存和致癌途径。
[这会更正文章DOI:10.1371 / journal.pone.0234103。]。
更新日期:2021-05-06
中文翻译:
更正:Fadraciclib(CYC065)是一种新型CDK抑制剂,靶向癌症中关键的促生存和致癌途径。
[这会更正文章DOI:10.1371 / journal.pone.0234103。]。